;PMID: 1673402
;source_file_896.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..45] = [t:0..45]
;1)sentence:[e:51..192] = [t:51..192]
;2)section:[e:196..258] = [t:196..258]
;3)section:[e:262..335] = [t:262..335]
;4)sentence:[e:339..486] = [t:339..486]
;5)sentence:[e:487..574] = [t:487..574]
;6)sentence:[e:575..669] = [t:575..669]
;7)sentence:[e:670..817] = [t:670..817]
;8)sentence:[e:818..967] = [t:818..967]
;9)sentence:[e:968..1160] = [t:968..1160]
;10)sentence:[e:1161..1414] = [t:1161..1414]
;11)section:[e:1418..1462] = [t:1418..1462]

;section 0 Span:0..45
;Drug Metab Dispos. 1991 Jan-Feb;19(1):218-21.
(SEC
  (FRAG (NNP:[0..4] Drug) (NNP:[5..10] Metab) (NNP:[11..17] Dispos)
        (.:[17..18] .) (CD:[19..23] 1991) (-RRB-:[24..28] Jan-)
        (CC:[28..35] Feb;19-LRB-) (CD:[35..36] 1) (-RRB-:[36..37] -RRB-)
        (CD:[37..41] :218) (::[41..42] -) (CD:[42..44] 21) (.:[44..45] .)))

;sentence 1 Span:51..192
;Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 
;8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
;[76..82]:substance:"enzyme"
;[111..147]:substance:"11-oxo-delta  8-tetrahydrocannabinol"
;[151..191]:substance:"delta 8-tetrahydrocannabinol-11-oic acid"
(SENT
  (NP-HLN
    (NP (NN:[51..56] Mouse) (JJ:[57..64] hepatic) (JJ:[65..75] microsomal)
        (NN:[76..82] enzyme))
    (SBAR
      (WHNP-1 (WDT:[83..87] that))
      (S
        (NP-SBJ-1 (-NONE-:[87..87] *T*))
        (VP (VBZ:[88..97] catalyzes)
          (NP
            (NP (NN:[98..107] oxidation))
            (PP (IN:[108..110] of)
              (NP (NN:[111..123] 11-oxo-delta)
                  (NN:[125..147] 8-tetrahydrocannabinol)))
            (PP (TO:[148..150] to)
              (NP (SYM:[151..156] delta)
                  (JJ:[157..186] 8-tetrahydrocannabinol-11-oic)
                  (NN:[187..191] acid)))))))
    (.:[191..192] .)))

;section 2 Span:196..258
;Watanabe K, Hirahashi N, Narimatsu S, Yamamoto I, Yoshimura H.
(SEC
  (FRAG (NNP:[196..204] Watanabe) (NNP:[205..206] K) (,:[206..207] ,)
        (NNP:[208..217] Hirahashi) (NNP:[218..219] N) (,:[219..220] ,)
        (NNP:[221..230] Narimatsu) (NNP:[231..233] S,) (NNP:[234..242] Yamamoto)
        (NNP:[243..244] I) (,:[244..245] ,) (NNP:[246..255] Yoshimura)
        (NNP:[256..258] H.)))

;section 3 Span:262..335
;Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan.
(SEC
  (FRAG (IN:[262..269] Faculty) (IN:[270..272] of)
        (NNP:[273..287] Pharmaceutical) (NNPS:[288..296] Sciences)
        (,:[296..297] ,) (NNP:[298..306] Hokuriku) (NNP:[307..317] University)
        (,:[317..318] ,) (NNP:[319..327] Kanazawa) (,:[327..328] ,)
        (NNP:[329..334] Japan) (.:[334..335] .)))

;sentence 4 Span:339..486
;Mouse hepatic microsomes oxidized 11-oxo-delta 8-tetrahydrocannabinol 
;(11-oxo-delta 8-THC, aldehyde) to delta 8-THC-11-oic-acid (carboxylic acid).
;[373..408]:substance:"11-oxo-delta 8-tetrahydrocannabinol"
;[411..429]:substance:"11-oxo-delta 8-THC"
;[431..439]:substance:"aldehyde"
;[444..467]:substance:"delta 8-THC-11-oic-acid"
;[469..484]:substance:"carboxylic acid"
(SENT
  (S
    (NP-SBJ (NN:[339..344] Mouse) (JJ:[345..352] hepatic)
            (NNS:[353..363] microsomes))
    (VP (VBD:[364..372] oxidized)
      (NP
        (NP (NN:[373..385] 11-oxo-delta) (NN:[386..408] 8-tetrahydrocannabinol))
        (NP (-LRB-:[410..411] -LRB-)
          (NP (NN:[411..423] 11-oxo-delta) (NN:[424..429] 8-THC))
          (,:[429..430] ,)
          (NP (NN:[431..439] aldehyde))
          (-RRB-:[439..440] -RRB-)))
      (PP (TO:[441..443] to)
        (NP
          (NP
            (NML (SYM:[444..449] delta) (JJ:[450..462] 8-THC-11-oic))
            (HYPH:[462..463] -) (NN:[463..467] acid))
          (NP (-LRB-:[468..469] -LRB-)
             (JJ:[469..479] carboxylic) (NN:[480..484] acid)
            (-RRB-:[484..485] -RRB-)))))
    (.:[485..486] .)))

;sentence 5 Span:487..574
;The  reaction required NADPH and molecular oxygen and showed an optimal pH
;around  7.5.
;[510..515]:substance:"NADPH"
;[530..536]:substance:"oxygen"
;[559..561]:quantitative-name:"pH"
;[570..573]:quantitative-value:"7.5"
(SENT
  (S
    (NP-SBJ (DT:[487..490] The) (NN:[492..500] reaction))
    (VP
      (VP (VBD:[501..509] required)
        (NP
          (NP (NN:[510..515] NADPH))
          (CC:[516..519] and)
          (NP (JJ:[520..529] molecular) (NN:[530..536] oxygen))))
      (CC:[537..540] and)
      (VP (VBD:[541..547] showed)
        (NP (DT:[548..550] an) (JJ:[551..558] optimal) (NN:[559..561] pH))
        (ADVP
          (QP (RB:[562..568] around) (CD:[570..573] 7.5)))))
    (.:[573..574] .)))

;sentence 6 Span:575..669
;The activity of NADPH-dependent carboxylic acid formation was mainly 
;localized in microsomes.
;[591..596]:substance:"NADPH"
;[607..622]:substance:"carboxylic acid"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[575..578] The) (NN:[579..587] activity))
      (PP (IN:[588..590] of)
        (NP
          (ADJP (NN:[591..596] NADPH) (HYPH:[596..597] -)
                (JJ:[597..606] dependent))
          (NML (JJ:[607..617] carboxylic) (NN:[618..622] acid))
          (NN:[623..632] formation))))
    (VP (VBD:[633..636] was)
      (ADVP (RB:[637..643] mainly))
      (VP (VBN:[645..654] localized)
        (NP-1 (-NONE-:[654..654] *))
        (PP-LOC (IN:[655..657] in)
          (NP (NNS:[658..668] microsomes)))))
    (.:[668..669] .)))

;sentence 7 Span:670..817
;The reaction was inhibited by various inhibitors of  cytochrome
;P-450-dependent oxidation such as SKF 525-A, alpha-naphthoflavone,  and
;metyrapone.
;[708..718]:substance:"inhibitors"
;[723..739]:cyp450:"cytochrome P-450"
;[768..777]:substance:"SKF 525-A"
;[779..799]:substance:"alpha-naphthoflavone"
;[806..816]:substance:"metyrapone"
(SENT
  (S
    (NP-SBJ-1 (DT:[670..673] The) (NN:[674..682] reaction))
    (VP (VBD:[683..686] was)
      (VP (VBN:[687..696] inhibited)
        (NP-1 (-NONE-:[696..696] *))
        (PP (IN:[697..699] by)
          (NP-LGS
            (NP (JJ:[700..707] various) (NNS:[708..718] inhibitors))
            (PP (IN:[719..721] of)
              (NP
                (ADJP
                  (NML (NN:[723..733] cytochrome) (NN:[734..739] P-450))
                  (HYPH:[739..740] -) (JJ:[740..749] dependent))
                (NN:[750..759] oxidation)))
            (PP (JJ:[760..764] such) (IN:[765..767] as)
              (NP
                (NP (NN:[768..771] SKF) (NN:[772..777] 525-A))
                (,:[777..778] ,)
                (NP (NN:[779..799] alpha-naphthoflavone))
                (,:[799..800] ,) (CC:[802..805] and)
                (NP (NN:[806..816] metyrapone))))))))
    (.:[816..817] .)))

;sentence 8 Span:818..967
;Disulfiram and menadione also inhibited the microsomal oxidation  of the
;aldehyde to the carboxylic acid, but pyrazole did not inhibit the  reaction.
;[818..828]:substance:"Disulfiram"
;[833..842]:substance:"menadione"
;[891..899]:substance:"aldehyde"
;[907..922]:substance:"carboxylic acid"
;[928..936]:substance:"pyrazole"
(SENT
  (S
    (S
      (NP-SBJ (NN:[818..828] Disulfiram) (CC:[829..832] and)
              (NN:[833..842] menadione))
      (ADVP (RB:[843..847] also))
      (VP (VBD:[848..857] inhibited)
        (NP
          (NP (DT:[858..861] the) (JJ:[862..872] microsomal)
              (NN:[873..882] oxidation))
          (PP (IN:[884..886] of)
            (NP (DT:[887..890] the) (NN:[891..899] aldehyde)))
          (PP (TO:[900..902] to)
            (NP (DT:[903..906] the)
               (JJ:[907..917] carboxylic) (NN:[918..922] acid))))))
    (,:[922..923] ,) (CC:[924..927] but)
    (S
      (NP-SBJ (NN:[928..936] pyrazole))
      (VP (VBD:[937..940] did) (RB:[941..944] not)
        (VP (VB:[945..952] inhibit)
          (NP (DT:[953..956] the) (NN:[958..966] reaction)))))
    (.:[966..967] .)))

;sentence 9 Span:968..1160
;The pretreatment of mice with phenobarbital significantly increased  the
;oxidation activity on the basis of microsomal protein, but did not affect it 
;on the basis of cytochrome P-450 content.
;[998..1011]:substance:"phenobarbital"
;[1087..1094]:substance:"protein"
;[1135..1151]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[968..971] The) (NN:[972..984] pretreatment))
      (PP (IN:[985..987] of)
        (NP (NNS:[988..992] mice)))
      (PP (IN:[993..997] with)
        (NP (NN:[998..1011] phenobarbital))))
    (VP
      (VP
        (ADVP (RB:[1012..1025] significantly))
        (VBD:[1026..1035] increased)
        (NP (DT:[1037..1040] the) (NN:[1041..1050] oxidation)
            (NN:[1051..1059] activity))
        (PP (IN:[1060..1062] on)
          (NP
            (NP (DT:[1063..1066] the) (NN:[1067..1072] basis))
            (PP (IN:[1073..1075] of)
              (NP (JJ:[1076..1086] microsomal) (NN:[1087..1094] protein))))))
      (,:[1094..1095] ,) (CC:[1096..1099] but)
      (VP (VBD:[1100..1103] did) (RB:[1104..1107] not)
        (VP (VB:[1108..1114] affect)
          (NP (PRP:[1115..1117] it))
          (PP (IN:[1119..1121] on)
            (NP
              (NP (DT:[1122..1125] the) (NN:[1126..1131] basis))
              (PP (IN:[1132..1134] of)
                (NP
                  (NML (NN:[1135..1145] cytochrome) (NN:[1146..1151] P-450))
                  (NN:[1152..1159] content))))))))
    (.:[1159..1160] .)))

;sentence 10 Span:1161..1414
;The mechanism for the oxidation of the  aldehyde to the carboxylic acid was
;confirmed to be oxygenation, since oxygen-18  was incorporated into delta
;8-THC-11-oic acid from molecular oxygen during the  hepatic microsomal
;oxidation of 11-oxo-delta 8-THC.
;[1201..1209]:substance:"aldehyde"
;[1217..1232]:substance:"carboxylic acid"
;[1272..1281]:substance:"oxygen-18"
;[1305..1328]:substance:"delta 8-THC-11-oic acid"
;[1344..1350]:substance:"oxygen"
;[1395..1413]:substance:"11-oxo-delta 8-THC"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1161..1164] The) (NN:[1165..1174] mechanism))
      (PP (IN:[1175..1178] for)
        (NP
          (NP (DT:[1179..1182] the) (NN:[1183..1192] oxidation))
          (PP (IN:[1193..1195] of)
            (NP (DT:[1196..1199] the) (NN:[1201..1209] aldehyde)))
          (PP (TO:[1210..1212] to)
            (NP (DT:[1213..1216] the)
               (JJ:[1217..1227] carboxylic) (NN:[1228..1232] acid))))))
    (VP (VBD:[1233..1236] was)
      (VP (VBN:[1237..1246] confirmed)
        (S
          (NP-SBJ-2 (-NONE-:[1246..1246] *))
          (VP (TO:[1247..1249] to)
            (VP (VB:[1250..1252] be)
              (NP-PRD (NN:[1253..1264] oxygenation)))))
        (,:[1264..1265] ,)
        (SBAR-ADV (IN:[1266..1271] since)
          (S
            (NP-SBJ-1 (NN:[1272..1281] oxygen-18))
            (VP (VBD:[1283..1286] was)
              (VP (VBN:[1287..1299] incorporated)
                (NP-1 (-NONE-:[1299..1299] *))
                (PP (IN:[1300..1304] into)
                  (NP
                    (NML (SYM:[1305..1310] delta) (JJ:[1311..1323] 8-THC-11-oic))
                    (NN:[1324..1328] acid)))
                (PP (IN:[1329..1333] from)
                  (NP (JJ:[1334..1343] molecular) (NN:[1344..1350] oxygen)))
                (PP-TMP (IN:[1351..1357] during)
                  (NP
                    (NP (DT:[1358..1361] the) (JJ:[1363..1370] hepatic)
                        (JJ:[1371..1381] microsomal) (NN:[1382..1391] oxidation))
                    (PP (IN:[1392..1394] of)
                      (NP (NN:[1395..1407] 11-oxo-delta) (NN:[1408..1413] 8-THC)))))))))))
    (.:[1413..1414] .)))

;section 11 Span:1418..1462
;PMID: 1673402 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1418..1422] PMID) (::[1422..1423] :) (CD:[1424..1431] 1673402)
        (NN:[1432..1433] -LSB-) (NNP:[1433..1439] PubMed) (::[1440..1441] -)
        (NN:[1442..1449] indexed) (IN:[1450..1453] for)
        (NNP:[1454..1462] MEDLINE-RSB-)))
